S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
S&P 500   3,443.12 (+0.47%)
DOW   28,308.79 (+0.40%)
QQQ   284.41 (+0.21%)
AAPL   117.51 (+1.32%)
MSFT   214.65 (+0.20%)
FB   267.56 (+2.36%)
GOOGL   1,551.08 (+1.38%)
AMZN   3,217.01 (+0.31%)
TSLA   421.94 (-2.06%)
NVDA   545.82 (+1.09%)
BABA   309.81 (+1.48%)
CGC   18.88 (-4.69%)
GE   7.34 (+0.69%)
MU   53.53 (+1.71%)
AMD   81.56 (-0.54%)
T   26.76 (-0.45%)
F   7.74 (+1.98%)
ACB   4.56 (-3.18%)
GILD   60.55 (-0.03%)
NFLX   525.42 (-1.00%)
BA   167.24 (+0.08%)
BAC   24.14 (+1.77%)
DIS   124.95 (+0.58%)
Log in
OTCMKTS:BAYRY

Bayer Stock Forecast, Price & News

$12.90
+0.03 (+0.23 %)
(As of 10/20/2020 03:59 PM ET)
Add
Compare
Today's Range
$12.83
Now: $12.90▼
$12.97
50-Day Range
$12.88
MA: $15.22▼
$16.94
52-Week Range
$12.55
Now: $12.90▼
$21.59
Volume1.51 million shs
Average Volume611,430 shs
Market Capitalization$48.12 billion
P/E RatioN/A
Dividend Yield4.12%
Beta1.15
Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Read More
Bayer logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.38 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BAYRY
Previous Symbol
CUSIPN/A
CIK1144145
Webwww.bayer.com
Phone49-21-4-30-1
Employees103,824

Debt

Debt-to-Equity Ratio0.95
Current Ratio0.90
Quick Ratio0.62

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio6.79
P/E Growth1.16

Sales & Book Value

Annual Sales$48.23 billion
Price / Sales1.00
Cash Flow$3.43 per share
Price / Cash Flow3.76
Book Value$14.27 per share
Price / Book0.90

Profitability

EPS (Most Recent Fiscal Year)$1.77
Net Income$4.58 billion
Net Margins-12.80%
Return on Equity14.64%
Return on Assets5.16%

Miscellaneous

Outstanding Shares3,730,200,000
Market Cap$48.12 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$12.90
+0.03 (+0.23 %)
(As of 10/20/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bayer (OTCMKTS:BAYRY) Frequently Asked Questions

How has Bayer's stock price been impacted by Coronavirus?

Bayer's stock was trading at $16.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BAYRY stock has decreased by 22.2% and is now trading at $12.90.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Bayer?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bayer in the last year. There are currently 1 sell rating, 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bayer.

When is Bayer's next earnings date?

Bayer is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Bayer.

How were Bayer's earnings last quarter?

Bayer AG (OTCMKTS:BAYRY) announced its earnings results on Tuesday, August, 4th. The company reported $0.44 earnings per share for the quarter. The company earned $11.07 billion during the quarter. Bayer had a negative net margin of 12.80% and a positive return on equity of 14.64%.
View Bayer's earnings history.

What guidance has Bayer issued on next quarter's earnings?

Bayer updated its FY 2020 Pre-Market earnings guidance on Tuesday, August, 4th. The company provided earnings per share (EPS) guidance of 7.05-7.27 for the period. The company issued revenue guidance of $46.255-47.356 billion, compared to the consensus revenue estimate of $50.8 billion.

Are investors shorting Bayer?

Bayer saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 135,200 shares, an increase of 18.2% from the August 31st total of 114,400 shares. Based on an average trading volume of 603,500 shares, the days-to-cover ratio is presently 0.2 days.
View Bayer's Short Interest.

Who are some of Bayer's key competitors?

Some companies that are related to Bayer include Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AbbVie (ABBV), Eli Lilly And Co (LLY), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), Commonwealth Bank of Australia (CSLLY), GlaxoSmithKline (GSK), Celgene (CELG), Zoetis (ZTS), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX) and Takeda Pharmaceutical (TAK).
View all competitors.

Who are Bayer's key executives?

Bayer's management team includes the following people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 57)
  • Mr. Wolfgang U. Nickl, CFO & Member of Management Board (Age 50)
  • Mr. Liam Condon, Pres of Bayer Crop Science Division & Member of Management Board (Age 51)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 57)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 63)

What is Bayer's stock symbol?

Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."

How do I buy shares of Bayer?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bayer's stock price today?

One share of BAYRY stock can currently be purchased for approximately $12.90.

How big of a company is Bayer?

Bayer has a market capitalization of $48.12 billion and generates $48.23 billion in revenue each year. The company earns $4.58 billion in net income (profit) each year or $1.77 on an earnings per share basis. Bayer employs 103,824 workers across the globe.

What is Bayer's official website?

The official website for Bayer is www.bayer.com.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]

This page was last updated on 10/20/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.